Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$145,000.00
Mar 1, 2024
For-profit organization
Atomic Components and Libraries
1016764
This project endeavours to improve the user experience through the implementation of third-party links and media libraries and create development efficiency of features through atomic component modeling.
$1,317,573.00
Mar 1, 2024
Not-for-profit organization or charity
IP Assist CtO
1016072
This project will enable North Forge Technology Exchange to administer a program for the benefit of IRAP clients.
$300,000.00
Mar 1, 2024
Academia
Intelligent Assistive Robots for Caregiving
1015008
It is timely and necessary to develop a digital CGA (D-CGA) which can support remote in-home assessment. When patients are assessed in a clinic or hospital, they may experience stress and confusion which can complicate an accurate assessment. Further, clinicians currently lack opportunity to observe how a patient navigates their home. A D-CGA may provide higher quality and more accurate information to inform care planning. The consortium will develop a D-CGA at Home (D-CGA@home) that leverages remote digital transformation and AI analysis. The DGA@home platform will facilitate wider use of CGA in Canada and Japan to increase clinicians’ ability to support older adults to age in place.
$821,314.00
Mar 1, 2024
For-profit organization
UKRI Biomanufacturing - 10101506 FF UB Stem Cell Proj - Utilization of Sustainable Growth Factors for the Automated Manufacture of Cellular Therapeutics
1015076
In this project, Future Fields (FF) will use cutting-edge genome editing techniques to engineer Drosophila melanogaster, where the stable stocks will be used to produce high functioning humanized growth factors required for our UK counterpart, Unicorn Biotechnologies (UB).
$24,000.00
Mar 1, 2024
For-profit organization
Development of Can Line Diagnostics and Service Guide & Enhancement of Cider Fermentation Process
1015599
The project focuses on enhancing cider quality through innovative fermentation techniques.
$16,000.00
Mar 1, 2024
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
1015889
The Project will support development of intellectual property capacity within the Firm
$50,000.00
Mar 1, 2024
For-profit organization
ICAP 2023 – International Co-Innovation Action Plan
1015896
The ICAP project will help the firm to expand into international markets for monitoring, reporting, and verification (MRV) of ocean carbon dioxide removal (oCDR).
$91,000.00
Mar 1, 2024
For-profit organization
Refining NBx for industrial performance
1015922
Novel NBx Platform significantly improves productivity in plasmid DNA manufacturing, securing patents for engineered bacteria. Beyond enhancing productivity, this organism produces higher-quality material with fewer host-related impurities, benefiting various bio-based products, especially protein-based ones like growth factors.
The Human Growth Factor market, relying on E.coli, faces challenges of low yields and batch failures. Novel's bacteria demonstrates lower endotoxin production and up to 20X productivity in plasmid DNA manufacturing compared to E.coli. Building on this success, Novel aims to create a disruptive manufacturing platform for EGF and FGF growth factors, anticipating these advantages will transfer to other bioproducts.
$75,000.00
Mar 1, 2024
For-profit organization
Drift Golf SaaS Platform Development
1015990
During this project, Drift Golf aims to complete the firm's MVP and bring a "customer-ready" software product to launch.
$75,000.00
Mar 1, 2024
For-profit organization
Tempeh Bacon
1015993
Development of an innovative pre-marinated Tempeh product with a strong emphasis on optimizing the physical characteristics of the Tempeh after the production process.